Aurinia Pharmaceuticals AUPH Finance Lease Liabilities (Total)

Finance Lease Liabilities (Total) at other companies

Rogers CorporationROG

$7.9M-16.8%

ANI PharmaceuticalsANIP

$152K-61.6%

Opko HealthOPK

$4.04M-23.1%

FAQ

What is Aurinia Pharmaceuticals's finance lease liabilities (total)?

Aurinia Pharmaceuticals (AUPH) reported finance lease liabilities (total) of $60.42M in Q2 2026.

How has Aurinia Pharmaceuticals's finance lease liabilities (total) changed year-over-year?

Aurinia Pharmaceuticals's finance lease liabilities (total) decreased by 19.9% year-over-year, from $75.45M to $60.42M.

What is the long-term trend for Aurinia Pharmaceuticals's finance lease liabilities (total)?

Over 2 years (2023 to 2025), Aurinia Pharmaceuticals's finance lease liabilities (total) has grown at a -12.6% compound annual growth rate (CAGR), from $90.09M to $68.85M.

What does finance lease liabilities (total) mean?

Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.